Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.findoc-cll.in | |
Market Cap | 11.57 Cr. | |
Enterprise Value(EV) | 5.68 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.89 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 24.35 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 42.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 34.29 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.34 | Calculated using Price: 45.92 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.25 Cr. | 2,519,100 Shares |
FaceValue | 10 | |
About Colinz Laboratories Ltd. | ||
Pharmaceutical Formulations (of all dosages forms) TabletsCapsulesParenteralsCreams/ Ointments/LotionsDry PowderLiquid OralsSoft Gelatine Capsules |
1 Day |
|
+9.52% |
1 Week |
|
+11.73% |
1 Month |
|
+13.16% |
3 Month |
|
+12.47% |
6 Month |
|
+14.60% |
1 Year |
|
+15.93% |
2 Year |
|
+76.25% |
5 Year |
|
+608.78% |
10 Year |
|
+1126.67% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 1.55 | 1.52 | 2.21 | 3.48 | 1.79 | 1.91 | 2.94 | 4.53 | 5.78 | |
Return on Capital Employed (%) | 3.12 | 3.27 | 3.12 | 3.25 | 3.45 | 3.3 | 4.28 | 6.76 | 7.86 | |
Return on Assets (%) | 0.94 | 0.93 | 1.45 | 2.39 | 1.3 | 1.45 | 2.2 | 3.39 | 4.54 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 9 | |
Non Curr. Liab. | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 2 | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | |
Minority Int. | |||||||||||
Equity & Liab. | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 | 11 | |
Non Curr. Assets | 5 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 3 | |
Curr. Assets | 6 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 8 | 8 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 11 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 | 11 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 8 | 8 | 8 | 8 | 8 | 8 | 6 | 7 | 7 | 7 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 8 | 8 | 8 | 8 | 8 | 8 | 6 | 7 | 7 | 7 | |
Total Expenditure | -7 | -8 | -8 | -8 | -7 | -7 | -6 | -6 | -7 | -7 | |
PBIDT | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 2 | 2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash Fr. Finan. | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Net Change | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | |
Cash & Cash Eqvt | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 5 | 5 | 6 |
Sat, 04 May 2024
Board Meeting Intimation for Notice Pf Board Meeting Pursuant Regulation 29(2) SEBI (LODR) Regulation 2015 COLINZ LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Notice pf Board Meeting Pursuant Regulation 29(2) SEBI (LODR) Regulation 2015. The Board Meeting is scheduled on 29th May 2024 for the Approval of Financial Results for the Quarter and Year ended on 31-03-2024 at the registered office of the company at 3.30 pm . Kindly take the same on records . |
Mon, 15 Apr 2024
Compliance Certificate Under Regulation 7(3) Of SEBI(LODR) Regulation 2015 For The Year Ended 31-03-2024 Please find the attached The certificate under Regulation 7(3) of SEBI(LODR) Regulation 2015 for the year ended 31-03-2024.Kindly take the same on records For Colinz Labs LtdDr. Mani L S.Compliance Officer |
Wed, 10 Apr 2024
Compliance Under Regulation 40(9) As On 31-03-24 Submission of certificate from practicing Company Secretary under Regulation 40(9) for the quarter ended as on 31-03-2024. |
Fri, 03 May 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Closing Above Previous High |
Close Within 52 Week High Zone |